Cosmo Pharmaceuticals N.V. (COPN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.8B |
| Enterprise Value | 1.75B |
| P/E Ratio | -166.35 |
| PEG Ratio | 1.62 |
| Price/Sales Ratio | 10.58 |
| Price/Book Ratio | 1.9 |
| Enterprise/Revenue | 10.32 |
| Enterprise/EBITDA | -1,664.78 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.06 |
| Operating Margin | -0.13 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 104.85M |
| Revenue/Share | 6.03 |
| Gross Profit | 48.78M |
| EBITDA | 2.36M |
| Net Income | -3.63M |
| Diluted EPS | -0.23 |
Balance Sheet
| Total Cash | 195.28M |
| Total Cash/Share | 11.46 |
| Total Debt | 4.33M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 10.66 |
| Book Value Per Share | 33.66 |
Price History
| 52-Week Change | 5.37 |
| 52-Week High | 129.4 |
| 52-Week Low | 53.4 |
| Moving Average 50 Days | 68.16 |
| Moving Average 200 Days | 85.58 |
Statistics
| Average Volume | 41,550 |
| Shares Outstanding | 17.19M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.09 |
| Trailing Annual Dividend Yield | 3.31 |
| Payout Ratio | -6.93 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
